232 related articles for article (PubMed ID: 32624540)
21. Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia.
Ueno H; Yoshida K; Shiozawa Y; Nannya Y; Iijima-Yamashita Y; Kiyokawa N; Shiraishi Y; Chiba K; Tanaka H; Isobe T; Seki M; Kimura S; Makishima H; Nakagawa MM; Kakiuchi N; Kataoka K; Yoshizato T; Nishijima D; Deguchi T; Ohki K; Sato A; Takahashi H; Hashii Y; Tokimasa S; Hara J; Kosaka Y; Kato K; Inukai T; Takita J; Imamura T; Miyano S; Manabe A; Horibe K; Ogawa S; Sanada M
Blood Adv; 2020 Oct; 4(20):5165-5173. PubMed ID: 33095873
[TBL] [Abstract][Full Text] [Related]
22. Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
Feng J; Li Y; Jia Y; Fang Q; Gong X; Dong X; Ru K; Li Q; Zhao X; Liu K; Wang M; Tian Z; Jia Y; Wang Y; Lin D; Wei H; Tang K; Mi Y; Wang J
J Hematol Oncol; 2017 Feb; 10(1):61. PubMed ID: 28245838
[TBL] [Abstract][Full Text] [Related]
23. Somatic and germline genomics in paediatric acute lymphoblastic leukaemia.
Pui CH; Nichols KE; Yang JJ
Nat Rev Clin Oncol; 2019 Apr; 16(4):227-240. PubMed ID: 30546053
[TBL] [Abstract][Full Text] [Related]
24. Genome sequencing of lymphoid malignancies.
Mullighan CG
Blood; 2013 Dec; 122(24):3899-907. PubMed ID: 24041576
[TBL] [Abstract][Full Text] [Related]
25. Genomic assessment of pediatric acute leukemia.
Mullighan CG; Flotho C; Downing JR
Cancer J; 2005; 11(4):268-82. PubMed ID: 16197717
[TBL] [Abstract][Full Text] [Related]
26. Next-generation-sequencing of recurrent childhood high hyperdiploid acute lymphoblastic leukemia reveals mutations typically associated with high risk patients.
Chen C; Bartenhagen C; Gombert M; Okpanyi V; Binder V; Röttgers S; Bradtke J; Teigler-Schlegel A; Harbott J; Ginzel S; Thiele R; Husemann P; Krell PF; Borkhardt A; Dugas M; Hu J; Fischer U
Leuk Res; 2015 Sep; 39(9):990-1001. PubMed ID: 26189108
[TBL] [Abstract][Full Text] [Related]
27. [Present status of individualized therapy in childhood acute lymphoblastic leukemia].
Wang J; Chen C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1617-22. PubMed ID: 24370059
[TBL] [Abstract][Full Text] [Related]
28. Childhood acute lymphoblastic leukemia: Integrating genomics into therapy.
Tasian SK; Loh ML; Hunger SP
Cancer; 2015 Oct; 121(20):3577-90. PubMed ID: 26194091
[TBL] [Abstract][Full Text] [Related]
29. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
[TBL] [Abstract][Full Text] [Related]
30. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
[TBL] [Abstract][Full Text] [Related]
31. Molecular-based and antibody-based targeted pharmacological approaches in childhood acute lymphoblastic leukemia.
Tardif M; Souza A; Krajinovic M; Bittencourt H; Tran TH
Expert Opin Pharmacother; 2021 Oct; 22(14):1871-1887. PubMed ID: 34011251
[No Abstract] [Full Text] [Related]
32. Driving Toward Precision Medicine for Acute Leukemias: Are We There Yet?
Chung C; Ma H
Pharmacotherapy; 2017 Sep; 37(9):1052-1072. PubMed ID: 28654205
[TBL] [Abstract][Full Text] [Related]
33. Genetic targets in pediatric acute lymphoblastic leukemia.
Gowda C; Dovat S
Adv Exp Med Biol; 2013; 779():327-40. PubMed ID: 23288647
[TBL] [Abstract][Full Text] [Related]
34. Treatment of pediatric acute lymphoblastic leukemia.
Cooper SL; Brown PA
Pediatr Clin North Am; 2015 Feb; 62(1):61-73. PubMed ID: 25435112
[TBL] [Abstract][Full Text] [Related]
35. New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances.
Simioni C; Bergamini F; Ferioli M; Rimondi E; Caruso L; Neri LM
Hematol Oncol; 2020 Feb; 38(1):22-33. PubMed ID: 31487068
[TBL] [Abstract][Full Text] [Related]
36. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia.
Xu H; Yu H; Jin R; Wu X; Chen H
Cells; 2021 Nov; 10(12):. PubMed ID: 34943855
[TBL] [Abstract][Full Text] [Related]
37. Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias.
Anselmi L; Bertuccio SN; Lonetti A; Prete A; Masetti R; Pession A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872391
[TBL] [Abstract][Full Text] [Related]
38. [Genetic and epigenetic landscape of pediatric T-cell acute lymphoblastic leukemia].
Kimura S
Rinsho Ketsueki; 2019; 60(5):459-467. PubMed ID: 31168014
[TBL] [Abstract][Full Text] [Related]
39. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.
Miyamoto K; Minami Y
Int J Clin Oncol; 2019 Aug; 24(8):893-898. PubMed ID: 31111287
[TBL] [Abstract][Full Text] [Related]
40. Towards personalized therapy in pediatric acute lymphoblastic leukemia: RAS mutations and prednisolone resistance.
Ariës IM; van den Dungen RE; Koudijs MJ; Cuppen E; Voest E; Molenaar JJ; Caron HN; Pieters R; den Boer ML
Haematologica; 2015 Apr; 100(4):e132-6. PubMed ID: 25480501
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
